Clinical Trials Sponsored by TrialX Inc

Total 37909 results

Canadian Cancer Trials Group
AstraZeneca

Active, not recruiting

Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours

Advanced Rare Tumours

Canada
Melt Pharmaceuticals
Worldwide Clinical Trials

Completed

Phase 1 Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual) and IV Midazolam or Ketamine

Healthy Volunteers

United States
Guangdong Association of Clinical Trials

Unknown

A Survival Observational Study in Patients With Advanced IIIB-IV Squamous Cell Lung Cancer Receiving PD-1 Combination With Chemotherapy

Lung Squamous Cell Carcinoma Stage IV

China
Guangdong Association of Clinical Trials

Unknown

The Impact of Neurocognitive Function in Patients With Multiple Brain Metastases Receiving Whole Brain Radiation Therapy

Brain Metastases

China
Arrien Pharmaceuticals
Worldwide Clinical Trials

Completed

A Phase 1 Study of ARN-6039 (ARN-6039)

Multiple Sclerosis
Orexo AB
Worldwide Clinical Trials

Completed

Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence

Opioid Dependence, on Agonist Therapy

United States
United Therapeutics
Asian Clinical Trials

Terminated

Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension (TRUST-1)

Pulmonary Arterial Hypertension

India
Scandinavian Critical Care Trials Group

Terminated

Scandinavian Intensive Care Unit (ICU) Glutamine Study

ICU Patients

Sweden
Usona Institute
Worldwide Clinical Trials

Recruiting

Psilocybin for Major Depressive Disorder (MDD) (uAspire)

Depressive Disorder, Major

United States
Scandinavian Critical Care Trials Group

Not yet recruiting

Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis (EMPRESS)

Sepsis | Septic Shock

Denmark
Guangdong Association of Clinical Trials

Recruiting

Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC

MRD

China
Guangdong Association of Clinical Trials

Recruiting

Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD

Non Small Cell Lung Cancer

China
Guangdong Association of Clinical Trials

Not yet recruiting

Osimertinib Plus Bevacizumab in Untreated EGFR Exon21 L858R Mutated NSCLC

Lung Cancer

China
Guangdong Association of Clinical Trials

Not yet recruiting

Efficacy and Safety of Camrelizumab in Real-World Prospective Study

Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials

Not yet recruiting

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Non-Small-Cell Lung Cancer
Alliance Foundation Trials, LLC.
Pfizer

Active, not recruiting

Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma

B Cell Lymphoma | Mantle Cell Lymphoma

United States
Canadian Cancer Trials Group
Pfizer

Active, not recruiting

Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer

Canada
KBP Biosciences
Worldwide Clinical Trials

Completed

Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease (BLOCKCKD)

Hypertension | Chronic Kidney Diseases

United States
Scandinavian Critical Care Trials Group

Completed

Does Rocking Charis Calm Delirious Patients in the Intensive Care Unit (RocingICU)

Delirium

Denmark
Canadian Cancer Trials Group
AstraZeneca

Active, not recruiting

Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

Canada
Canadian Cancer Trials Group
AstraZeneca

Active, not recruiting

Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens

Solid Malignancies

Canada
Canadian Cancer Trials Group
AstraZeneca

Completed

Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer

Colorectal Cancer

Canada
Canadian Cancer Trials Group
AstraZeneca

Active, not recruiting

Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

Canada
Canadian Cancer Trials Group
Pfizer

Completed

Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

Refractory Lymphoma | Recurrent Lymphoma | Solid Tumours | Central Nervous System

Canada
Microphyt
Atlantia Food Clinical Trials

Completed

Effect of BrainPhyt, a Microalgae Based Ingredient on Cognitive Function in Healthy Older Subjects (PHAEOSOL-THREE)

Stress | Cognitive Impairment | Sleep | Healthy Aging | Mood | Dietary Supplement | Neuroprotection | Fucoxanthin

Ireland
Cancer Trials Ireland
Janssen, LP

Completed

Neo-adjuvant Abiraterone Prostate Study

High Risk Localised Prostate Carcinoma

Ireland
R-Pharm
OCT Clinical Trials

Completed

Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia

Pneumonia, Bacterial

Russian Federation
Melt Pharmaceuticals
Worldwide Clinical Trials

Completed

A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)

Cataract

United States
UNICANCER
Canadian Cancer Trials Group

Completed

Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)

Canada, France
Australasian Gastro-Intestinal Trials Group

Completed

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer (MODULATE)

Colorectal Cancer Metastatic

Australia
Guangdong Association of Clinical Trials

Unknown

Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment

Small Cell Lung Cancer

China
Guangdong Association of Clinical Trials

Unknown

Efficacy and Safety of Camrelizumab in Real-World Study

Non-small Cell Lung Cancer

China
Guangdong Association of Clinical Trials

Unknown

Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure

Non-small Cell Lung Cancer

China
Guangdong Association of Clinical Trials

Completed

Third-line Treatment of Gefitinib in NSCLC Patients

Non Small Cell Lung Cancer

China
Guangdong Association of Clinical Trials

Unknown

Anlotinib Plus Pemetrexed or Pemetrexed for Previously Untreated Elderly (>=70) or PS=2 Non-squamous NSCLC

Advanced Non-squamous NSCLC

China
Guangdong Association of Clinical Trials

Unknown

Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in NSCLC Patients Activating EGFR Mutations

NSCLC

China
Orexo AB
Worldwide Clinical Trials

Completed

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

Opioid-Related Disorders | Opiate Dependence

United States
Orexo AB
Worldwide Clinical Trials

Completed

Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults (ISTART)

Opioid Dependence, on Agonist Therapy

United States
Guangdong Association of Clinical Trials

Terminated

Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation (INNOVATE)

Non-small-cell Lung Cancer

China
Guangdong Association of Clinical Trials

Completed

Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients (CHOICE)

Non Small Cell Lung Cancer
Guangdong Association of Clinical Trials

Completed

A Prospective Epidemiologic Study of ALK-Positive NSCLC in China (C-TALK)

Non-small-cell Lung Cancer

China
Bayer
International Clinical Trials Association

Completed

Survey to Assess Why People Are Not Responding to Treatment in Hypertension

Arterial Hypertension

France
Norgine
International Clinical Trials Association

Completed

A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation (NORMO)

Gastrointestinal Diseases

France
Australasian Gastro-Intestinal Trials Group

Completed

The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Australia, New Zealand
Australasian Gastro-Intestinal Trials Group

Recruiting

A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study (PALEO)

Oesophageal Cancer

Australia, New Zealand
Guangdong Association of Clinical Trials

Recruiting

Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLC

ALK Positive Non-small Cell Lung Cancer

China
Canadian Cancer Trials Group
Novartis

Recruiting

Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer

NSCLC

Canada
Guangdong Association of Clinical Trials

Recruiting

Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study (BELLA)

NSCLC

China
Guangdong Association of Clinical Trials

Not yet recruiting

An Open Label, Multicenter, Phase II Study of Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases

Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases
Alliance Foundation Trials, LLC.
Bayer

Recruiting

Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide (ARACOG)

Prostate Cancer | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Castrate Resistant Prostate Cancer

United States

3

Subscribe